Role of MAP3K14 in prevention and treatment of acute renal failure

Developed by: Instituto de Investigación Sanitaria Fundación Jiménez Díaz

Description

Description

 Inhibition of MAP3K14 by siRNA decreases the inflammation caused by acute kidney damage by, at least, regulating cytokine secretion and preserving renal function by inhibiting cell death through apoptosis.

Applications

Use of MAP3K14 inhibitors in treatment and prevention of acute kidney damage.

Protection status

Co-ownership of the invention.

Request for national patent submitted to the Spanish Patent and Trademark Office.

Cooperation requested

Search for licensees for the patent

Search for partners to undertake joint development of the technology

Therapy area

Nephrology

Immunology

Technology Area

Biotechnology and molecular diagnosis

Status:
N/A
Health technology:
N/A